Exploring novel capping framework: high substituent pyridine-hydroxamic acid derivatives as potential antiproliferative agents-Reference-Cited by-同舟云学术

Exploring novel capping framework: high substituent pyridine-hydroxamic acid derivatives as potential antiproliferative agents

Published:2021-07-23 Issue:2 Volume:29 Page:291-310
ISSN:2008-2231
Container-title:DARU Journal of Pharmaceutical Sciences
language:en
Short-container-title:DARU J Pharm Sci

Author:

Hernández-Borja Fernando,Mercado-Sánchez Itzel,Alcaraz Yolanda,García-Revilla Marco A.,Villegas Gómez Clarisa,Ordaz-Rosado David,Santos-Martínez Nancy,García-Becerra Rocío,Vazquez Miguel A.^ORCID

Funder

Consejo Nacional de Ciencia y Tecnología

DAIP-Universidad de Guanajuato

Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica-PAPIIT

Publisher

Springer Science and Business Media LLC

Subject

Applied Mathematics,General Mathematics

Link

https://link.springer.com/content/pdf/10.1007/s40199-021-00406-8.pdf

Reference59 articles.

1. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–63.

2. Wang A, Qu L, Wang L. At the crossroads of cancer stem cells and targeted therapy resistance. Cancer Lett. 2017;385:87–96.

3. Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res. 2007;5:981–9.

4. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007;26:5541–52.

5. West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124:30–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship;Journal of Molecular Structure;2025-02

2. Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities;DARU Journal of Pharmaceutical Sciences;2024-04-29

3. Recent Developments of Hydroxamic Acid Hybrids as Potential Anti-Breast Cancer Agents;Future Medicinal Chemistry;2024-01-31

4. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design;Bioorganic Chemistry;2023-09

5. Keggin heteropolyacid in auto-tandem catalysis: confinement effects over ordered mesoporous silica in the synthesis of 2-pyridones;New Journal of Chemistry;2023